M
Matthew E. Falagas
Researcher at Tufts University
Publications - 690
Citations - 57206
Matthew E. Falagas is an academic researcher from Tufts University. The author has contributed to research in topics: Colistin & Randomized controlled trial. The author has an hindex of 109, co-authored 688 publications receiving 49703 citations. Previous affiliations of Matthew E. Falagas include Tufts Medical Center & American Institute of Biological Sciences.
Papers
More filters
Journal ArticleDOI
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A-P Magiorakos,Arjun Srinivasan,R B Carey,Yehuda Carmeli,Matthew E. Falagas,Matthew E. Falagas,Christian G. Giske,Stéphan Juergen Harbarth,Janet F. Hindler,Gunnar Kahlmeter,Barbro Olsson-Liljequist,David L. Paterson,Louis B. Rice,John Stelling,Marc Struelens,Alkiviadis Vatopoulos,J T Weber,Dominique L Monnet +17 more
TL;DR: A group of international experts came together through a joint initiative by the European Centre for Disease Prevention and Control and the Centers for Disease Control and Prevention, to create a standardized international terminology with which to describe acquired resistance profiles in Staphylococcus aureus, Enterococcus spp.
Journal ArticleDOI
Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses
TL;DR: The content coverage and practical utility of PubMed, Scopus, Web of Science, and Google Scholar are compared and PubMed remains an optimal tool in biomedical electronic research.
Journal ArticleDOI
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
TL;DR: Recent studies of patients who received intravenous polymyxins for the treatment of serious P. aeruginosa and Acinetobacter baumannii infections of various types, including pneumonia, bacteremia, and urinary tract infections, have led to the conclusion that these antibiotics have acceptable effectiveness and considerably less toxicity than was reported in old studies.
Factors associated with
TL;DR: The suboptimal compliance to vaccinations continues to be a major public health problem and the number of children receiving vaccinations is on the rise.
Journal ArticleDOI
Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
TL;DR: The authors sought to evaluate the current global status of T. gondii seroprevalence and its correlations with risk factors, environmental and socioeconomic parameters, and recognise specific risk factors related to seropositivity; however, such risk factors are not reported systematically.